Filing Details
- Accession Number:
- 0001209191-20-007047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 20:13:48
- Reporting Period:
- 2020-02-04
- Accepted Time:
- 2020-02-05 20:13:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645666 | Kezar Life Sciences Inc. | KZR | Pharmaceutical Preparations (2834) | 473366145 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744253 | J. Christopher Kirk | C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080 | President And Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-04 | 38,461 | $2.60 | 342,609 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.
- Total reflects 1,214 shares of common stock acquired on November 15, 2019 through the Company's 2018 Employee Stock Purchase Plan.
Billionaire Hedge Funds
